GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Total Debt History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹160 Cr | ₹30 Cr | - | - | - |
What is the latest Total Debt ratio of GUJARAT THEMIS BIOSYN ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹160 Cr |
| Mar2025 | ₹30 Cr |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
How is Total Debt of GUJARAT THEMIS BIOSYN Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹160 Cr | 434.85 | |
| Mar2025 | ₹30 Cr | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | - | |
Compare Total Debt of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹4,719.8 Cr | 7.3% | -10.4% | -17.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | 7.3% |
-10.4% |
-17.6% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses